CAS RN: 912445-05-7
ABT-888
Product Availability
Choose a grade to view its available package options.
7 package records4 with current stock3 grade groups
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20251127 |
5mg / 10mg / 25mg / 100mg / 250mg |
Confirm by inquiry |
Shanghai, Guangdong | Inquiry |
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250622 |
10mg |
In stock |
Shanghai | Inquiry |
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20251015 |
100mg |
Out of stock |
| Inquiry |
| Batchno.20250904 |
10mg |
In stock |
Shanghai | Inquiry |
| Batchno.20250906 |
1g |
Out of stock |
| Inquiry |
| Batchno.20260614 |
250mg |
Out of stock |
| Inquiry |
| Batchno.20260317 |
5mg |
In stock |
Shanghai | Inquiry |
-
Product code:
starshine_CAS912445-05-7
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
912445-05-7 / 2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide
Standard CAS: 912445-05-7
Multi CAS: Yes
Basic Information
CAS
912445-05-7
Multi CAS
Yes
Molecular Formula
C13H16N4O
Molecular Weight
244.290000
Exact Mass
244.132411
InChI
InChI=1S/C13H16N4O.2ClH/c1-13(6-3-7-15-13)12-16-9-5-2-4-8(11(14)18)10(9)17-12;;/h2,4-5,15H,3,6-7H2,1H3,(H2,14,18)(H,16,17);2*1H/t13-;;/m1../s1
InChIKey
DSBSVDCHFMEYBX-FFXKMJQXSA-N
Computed Properties
Structural Parameters
Heavy atom count
18
Aromatic heavy atom count
9
Fraction Csp3
0.38
Rotatable bonds
2
H-bond acceptors
3
H-bond donors
3
Molar refractivity
69.2
TPSA
83.8
LogP / Solubility
WLOGP
1.26
MLOGP
1.11
XLogP3
0.5
Consensus LogP
0.96
Log S (ESOL)
-2.39
Class (ESOL)
Moderately soluble
Log S (Ali)
-2.47
Class (Ali)
Moderately soluble
Log S (SILICOS-IT)
-2.53
Class (SILICOS-IT)
Moderately soluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-3.32
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
2